valsartan
Commercial- Indications
- Hypertension
Company intelligence / Profile preview
Zhejiang Tianyu Pharmaceutical is a leading global supplier of advanced pharmaceutical intermediates and specialty APIs. The company has a strong commercial presence in chronic disease markets—especially antihypertensive drugs (“sartans”), antidiabetics (e.g., saxagliptin intermediates), anticoagulants and anti-asthmatics. It supplies both originator and generic companies worldwide with GMP-compliant products. The company has received regulatory approvals from the US FDA and EU authorities but has faced recent FDA warning letters regarding manufacturing practices[7][10]. R&D focuses on new chemical entities for cardiovascular/metabolic diseases as well as oncology and antivirals.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Tianyu Pharmaceutical.